BioLineRx to Report Second Quarter 2024 Results on August 15, 2024

Go back to BioLineRx to Report Second Quarter 2024 Results on August 15, 2024
BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.76 +0.06 (2.22%)
Previous Close $2.70    52 Week High $1.63 
Open $2.85    52 Week Low $0.71 
Day High $2.85    P/E N/A 
Day Low $2.76    EPS $0.00 
Volume 2,271       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.76 +0.06 (2.22%)
Previous Close $2.70    52 Week High $1.63 
Open $2.85    52 Week Low $0.71 
Day High $2.85    P/E N/A 
Day Low $2.76    EPS $0.00 
Volume 2,271